| Literature DB >> 33869749 |
Vincent Wu1, Mirko Manojlovic Kolarski1, Christopher E Kandel2, Eric Monteiro1, Yvonne Chan1.
Abstract
OBJECTIVE: There are no consensus guidelines for managing peritonsillar abscess (PTA) despite its prevalence. In order to devise best practice guidelines, current practice patterns must first be established.Entities:
Keywords: antibiotics; management; otolaryngology; peritonsillar abscess
Year: 2021 PMID: 33869749 PMCID: PMC8035939 DOI: 10.1002/lio2.538
Source DB: PubMed Journal: Laryngoscope Investig Otolaryngol ISSN: 2378-8038
Demographic information
| Characteristics | Combined (n = 57) | Trainee (n = 24) | Consultant (n = 33) |
|
|---|---|---|---|---|
| Age (years, SD, range) | 40.8, SD 13.9, range 25‐79 | 30.5, SD 3.9, range 25‐37 | 48.8, SD 13.5, range 32‐79 | .0001 |
| Gender male (n, %) | 43 (75%) | 18 (75%) | 25 (76%) | 1.00 |
| Time in training/time in practice (years, SD, range) | 11.5, SD 11.7, range 1‐45 | 3.8, SD 1.9, range 1‐6 | 17.1, SD 12.7, range 1‐45 | .0001 |
| # PTA managed last year (n, SD, range) | 15.2, SD 11.2, range 0‐50 | 15.4 SD 12.8, range 0‐50 | 15.0, SD 10.2, range 0‐50 | .84 |
PTA management practices and differences between trainee and consultant
| Management | Combined (n = 57) | Trainee (n = 24) | Consultant (n = 33) |
|
|---|---|---|---|---|
| Manual palpation (n, %) | 33 (58%) | 15 (63%) | 18 (55%) | .60 |
| Flexible nasolaryngoscopy (n, %) | 17 (30%) | 6 (25%) | 11 (33%) | .57 |
| Blood work (n, %) | 39 (68%) | 18 (75%) | 21 (64%) | .40 |
| IV antibiotics (n, %) | 44 (77%) | 19 (79%) | 25 (76%) | 1.00 |
| IV steroids (n, %) | 43 (75%) | 20 (83%) | 23 (70%) | .35 |
| Imaging (n, %) | 6 (11%) | 3 (13%) | 3 (9%) | .69 |
| Needle aspiration (n, %) | 41 (72%) | 19 (79%) | 22 (67%) | .38 |
| Incision and drainage (n, %) | 52 (91%) | 22 (92%) | 30 (91%) | 1.00 |
| Culture and sensitivity (n, %) | 41 (72%) | 18 (75%) | 23 (70%) | .77 |
| Prescribe opioids (n, %) | 36 (63%) | 13 (54%) | 23 (70%) | .27 |
| Prescribe non‐opioids (n, %) | 46 (81%) | 19 (79%) | 27 (82%) | 1.00 |
| Prescribe oral steroids (n, %) | 9 (16%) | 2 (8%) | 7 (21%) | .28 |
| Arrange follow‐up (n, %) | 42 (74%) | 16 (67%) | 26 (79%) | .37 |
| Follow‐up with OHNS (n, %) | 27 (64%) | 6 (38%) | 21 (81%) | .0077 |
| Follow‐up time (days, SD) | 12.5 (8.2) | 11.7 (6.5) | 13.0 (9.2) | .71 |